+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Peripheral Nerve Injuries - Pipeline Insight, 2025 - Product Thumbnail Image

Peripheral Nerve Injuries - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Otomycosis - Pipeline Insight, 2025 - Product Thumbnail Image

Otomycosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Gonorrhoea - Pipeline Insight, 2025 - Product Thumbnail Image

Gonorrhoea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Diabetic Ketoacidosis - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Ketoacidosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Human Papillomavirus 16-positive (HPV16+) Cancers- Pipeline Insight, 2025 - Product Thumbnail Image

Human Papillomavirus 16-positive (HPV16+) Cancers- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Biliary Atresia - Pipeline Insight, 2025 - Product Thumbnail Image

Biliary Atresia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Corneal Endothelial Dystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Corneal Endothelial Dystrophy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
Abnormal Glucose Tolerance- - Pipeline Insight, 2025 - Product Thumbnail Image

Abnormal Glucose Tolerance- - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Pericarditis - Pipeline Insight, 2025 - Product Thumbnail Image

Pericarditis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Minimal Change Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Minimal Change Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Vascular Calcification - Pipeline Insight, 2025 - Product Thumbnail Image

Vascular Calcification - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Ocular Inflammation And Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Ocular Inflammation And Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
LRRK2 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

LRRK2 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
RIPK1 Inhibitor - Pipeline Insights, 2025 - Product Thumbnail Image

RIPK1 Inhibitor - Pipeline Insights, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Metastatic Bone Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Bone Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
MELAS Sundrome - Pipeline Insight, 2025 - Product Thumbnail Image

MELAS Sundrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
Ragweed Pollen Hypersensitivity - Pipeline Insight, 2025 - Product Thumbnail Image

Ragweed Pollen Hypersensitivity - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Advanced Renal Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Renal Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more